To award task order E03 entitled "lead optimization screening assays for safety profiling" in the base award amount of $102,981.15.
Ended Awarded Last action
- Contract number
- 75N93019F00131
- Awardee
-
Eurofins Discovery Services North America, LLC UEI HF4LCAU68M93
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $77,514
Award facts
- Opportunity
-
- NIHAI2017090 Solicitation number
- Nonclinical Services for Development of Interventional Agents for Infectious Diseases Award Notice · Posted Feb 13, 2017
- Contract value 56% obligated
-
- $77,514.30 Current, with exercised options
- $137,856.75 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- St Peters, MO 63304, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$25,467 | |
| Original award | $102,981 |
About this award
This task order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc. under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Nonclinical Services for Development of Interventional Agents. The task order, valued at $102,981.15, is for "Lead Optimization Screening Assays for Safety Profiling" and has a total potential value of $137,856.75. Eurofins Panlabs, a foreign-owned for-profit organization, has previously provided research and development services to agencies such as the Environmental Protection Agency, NIH, Food and Drug Administration, and Department of Veterans Affairs. This task order does not have a set-aside designation.
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to Eurofins Discovery Services North America, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 5, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $77,514 on 75N93019F00131. Its potential value, with all options, is $137,857.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under 75N93018D00007, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award